Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029–30.

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J CLIN. 2021;71:209–49.

Article  PubMed  Google Scholar 

Zhang CL, Huang T, Wu BL, He WX, Liu D. Stem cells in cancer therapy: opportunities and challenges. Oncotarget. 2017;8(43):75756–66.

Article  PubMed  PubMed Central  Google Scholar 

Sarukhan A, Zanotti L, Viola A. Mesenchymal stem cells: myths and reality. Swiss Med Wkly. 2015;145:w14229. https://doi.org/10.4414/smw.2015.14229.

Article  CAS  PubMed  Google Scholar 

Francois S, Usunier B, Forgue-Lafitte ME, L’Homme B, Benderitter M, Douay L, et al. Mesenchymal stem cell administration attenuates colon cancer progression by modulating the immune component within the colorectal tumor microenvironment. Stem Cells Transl Med. 2019;8(3):285–300.

Article  CAS  PubMed  Google Scholar 

Ebadi Zavieh S, Safari F. The antitumor activity of hAMSCs Secretome in HT-29 colon cancer cells through downregulation of EGFR/c-Src/IRTKS expression and p38/ERK1/2 phosphorylation. Cell Biochem Biophys. 2022;80(2):395–402.

Article  CAS  PubMed  Google Scholar 

Safari F, Ansari Dogaheh F, Dadashi H. Evaluation of SgK269 expression in colon cancer patients and the effects of hAMSCs secretome on tumor invasion through SgK269/c-Src/p-P130Cas/p-Paxillin/p-ERK1/2 signaling pathway in HT-29 colon cancer cells. 3 Biotech. 2023;13:346.

Article  PubMed  Google Scholar 

Safari F, Suetsugu S. The bar domain superfamily proteins from subcellular structures to human diseases. Membrane. 2012;2:91–1170.

Article  CAS  Google Scholar 

Yeh TC, Ogawa W, Danielsen AG, Roth RA. Characterization and cloning of a 58/53-kDa substrate of the insulin receptor tyro-sine kinase. J Biol Chem. 1996;271:2921–8.

Article  CAS  PubMed  Google Scholar 

Hu RM, Han ZG, Song HD, Peng YD, Huang QH, Ren SX, et al. Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning. Proc Natl Acad Sci USA. 2000;97:9543–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen G, Li T, Zhang L, Yi M, Chen F, Wang Z, et al. Src-stimulated IRTKS phosphorylation enhances cell migration. FEBS Lett. 2011;585:2972–8.

Article  CAS  PubMed  Google Scholar 

Lia L, Liuc H, Baxterb SS, Gu N, Ji M, Zhang X. The SH3 domain distinguishes the role of I-BAR proteins IRTKS and MIM in chemotactic response to serum. Biochem Biophys Res Commun. 2016;479(4):787–92.

Article  Google Scholar 

Wu C, Cui X, Huang L, Shang X, Wu B, Wang N, et al. IRTKS promotes insulin signaling transduction through inhibiting SHIP2 phosphatase activity. Int J of Mol Sci. 2019;20(11):2834.

Article  CAS  Google Scholar 

van Dop M, Fiedler M, Mutte S, de Keijzer J, Olijslager L, Albrecht C, et al. DIX domain polymerization drives assembly of plant cell polarity complexes. Cell. 2020;180(3):427-39.e12.

Article  PubMed  PubMed Central  Google Scholar 

Nelson WJ. Adaptation of core mechanisms to generate cell polarity. Nature. 2003;422(6933):766–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mellman I, Nelson WJ. Coordinated protein sorting, targeting and distribution in polarized cells. Nat Rev Mol Cell Biol. 2008;9(11):833–45.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Suzuki A, Ohno S. The PAR-aPKC system: lessons in polarity. J Cell Sci. 2006;119(Pt 6):979–87.

Article  CAS  PubMed  Google Scholar 

Rahmani Z, Safari F. Evaluating the in vitro therapeutic effects of human amniotic mesenchymal stromal cells on MiaPaca2 pancreatic cancer cells using 2D and 3D cell culture model. Tissue Cell. 2020;68:101479. https://doi.org/10.1016/j.tice.2020.101479.

Article  CAS  PubMed  Google Scholar 

Safari F, Shakery T, Sayadamin N. Evaluating the effect of secretome of human amniotic mesenchymal stromal cells on apoptosis induction and epithelial-mesenchymal transition inhibition in LNCaP prostate cancer cells based on 2D and 3D cell culture models. Cell Biochem Funct. 2021;39(6):813–20.

Article  CAS  PubMed  Google Scholar 

Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial– mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nijkamp MM, Span PN, Hoogsteen IJ, van der Kogel AJ, Kaanders JH, Bussink J. Expression of E-cadherin and vimentin correlates with metastasis formation in head and neck squamous cell carcinoma patients. Radiother Oncol. 2011;99:344–8. https://doi.org/10.1016/j.radonc.2011.05.066.

Article  CAS  PubMed  Google Scholar 

Humbert PO, Grzeschik NA, Brumby AM, Galea R, Elsum I, Richardson HE. Control of tumourigenesis by the Scribble/Dlg/Lgl polarity module. Oncogene. 2008;27:6888–907.

Article  CAS  PubMed  Google Scholar 

Lee M, Vasioukhin V. Cell polarity and cancer–cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci. 2008;121(Part 8):1141–50.

Article  CAS  PubMed  Google Scholar 

Joberty G, Petersen C, Gao L, Macara IG. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol. 2000;2:531–9.

Article  CAS  PubMed  Google Scholar 

Mirouse V, Billaud M. The LKB1/AMPK polarity pathway. FEBS Letter. 2011;585(7):981–5.

Article  CAS  Google Scholar 

Shakery T, Safari F. Downregulation of Pinkbar/pAKT and MMP2/MMP9 expression in MDA-MB-231 breast cancer cells as potential targets in cancer therapy by hAMSCs secretome. Cells Tissues Organs. 2023;212(2):155–63. https://doi.org/10.1159/000520370.

Article  CAS  PubMed  Google Scholar 

Safari F, Bararpour S, Omidi CF. The suppression of cell motility through the reduction of FAK activity and expression of cell adhesion proteins by hAMSCs secretome in MDA-MB-231 breast cancer cells. Invest New Drugs. 2024. https://doi.org/10.1007/s10637-024-01434-2.

Article  PubMed  Google Scholar 

Safari F, ShafieeNejad N, AghaeiNejad A. The inhibition of Panc1 cancer cells invasion by hAMSCs secretome through suppression of tyrosine phosphorylation of SGK223 (at Y411 site), c-Src (at Y416, Y530 sites), AKT activity, and JAK1/ Stat3 signaling. Med Oncol. 2022;39(3):28. https://doi.org/10.1007/s12032-022-01649-4.

Article  CAS  PubMed  Google Scholar 

AlidoustSaharkhizLahiji M, Safari F. Potential therapeutic effects of hAMSCs secretome on Panc1 pancreatic cancer cells through downregulation of SgK269, E-cadherin, vimentin, and snail expression. Biologicals. 2022;76:24–30.

Article  CAS  Google Scholar 

Sierra A. Metastases and their microenviroments: linking pathogenesis and therapy. Drug Resist Updat. 2005;8:247–57.

Article  CAS  PubMed  Google Scholar 

Chen D, Liu S, Ma H, Liang X, Ma H, Yan X, et al. Paracrine factors from adiposemesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model. Cancer Cell Int. 2015;15:42.

Article  PubMed